Summary & Overview
HCPCS G0090: Initial Home Visit for IV Chemotherapy or Complex Infusion
HCPCS Level II code G0090 designates the professional initial visit for administration of intravenous chemotherapy or other highly complex infusion drugs or biologicals in the patient’s home, billed in 15-minute increments per infusion drug administration calendar day. This code reflects the growing delivery of complex infusion therapies outside traditional infusion centers and is significant for payers, home health agencies, and oncology practices managing home-based treatment models. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code covers, typical clinical and operational contexts for home-based IV infusions, and the types of benchmarks and policy considerations commonly associated with home infusion professional services. The publication outlines payment and utilization benchmarks, billing guidance highlights, and relevant policy updates that affect coverage and documentation requirements. Where specific data elements are unavailable in the input, the publication notes that Data not available in the input. This summary provides clinicians, practice managers, and payer analysts with a practical reference to understand billing scope, expected site of service, and the operational implications of using HCPCS Level II code G0090 for initial home infusion visits.
Billing Code Overview
HCPCS Level II code G0090 describes professional services for the initial visit to administer intravenous chemotherapy or other highly complex infusion drugs or biologicals in the patient’s home. The code is billed for each infusion drug administration calendar day and is reported in 15-minute increments for the clinician’s professional time during the initial home infusion visit.
Service type: Home-based infusion professional services
Typical site of service: Patient's home
Clinical & Coding Specifications
Clinical Context
A home infusion nurse practitioner or oncology infusion specialist conducts an initial professional visit to administer an intravenous chemotherapy agent or another highly complex infusion drug or biological in the patient’s residence. The patient is typically an adult or pediatric oncology patient with an established diagnosis requiring parenteral oncology therapy who cannot safely travel to an outpatient infusion center due to frailty, immunosuppression, transportation barriers, or palliative care needs. The encounter includes review of the chemotherapy order, verification of informed consent, assessment of current clinical status and vital signs, peripheral or central venous access evaluation, sterile preparation and administration of the infusion, continuous monitoring for acute infusion reactions, documentation of drug lot and dose, management of immediate side effects, and coordination of follow-up care. Each 15-minute segment of direct professional time spent for the initial home infusion visit is reported using G0090 with appropriate modifier(s) to reflect professional component, site, or special circumstances.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the professional (physician or non-physician practitioner) service is being reported separate from supplies or technical services provided by another entity. |